pilocarpine has been researched along with Arteriosclerosis, Coronary in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the coronary arteries reactivity alterations in rats with epilepsy induced by pilocarpine." | 7.91 | Coronary vasodilation impairment in pilocarpine model of epilepsy. ( Colugnati, DB; da Silva, M; de Castro, CH; Dos Santos, FCA; Ghazale, PP; Gomes, KP; Mendes, EP; Pansani, AP; Scorza, FA; Vitorino, PR, 2019) |
"We investigated the coronary arteries reactivity alterations in rats with epilepsy induced by pilocarpine." | 3.91 | Coronary vasodilation impairment in pilocarpine model of epilepsy. ( Colugnati, DB; da Silva, M; de Castro, CH; Dos Santos, FCA; Ghazale, PP; Gomes, KP; Mendes, EP; Pansani, AP; Scorza, FA; Vitorino, PR, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YY | 1 |
Lai, YJ | 1 |
Yen, YF | 1 |
Shen, YC | 1 |
Wang, CY | 1 |
Liang, CY | 1 |
Lin, KH | 1 |
Fan, LW | 1 |
Vitorino, PR | 1 |
Gomes, KP | 1 |
Ghazale, PP | 1 |
da Silva, M | 1 |
Mendes, EP | 1 |
Dos Santos, FCA | 1 |
Pansani, AP | 1 |
de Castro, CH | 1 |
Scorza, FA | 1 |
Colugnati, DB | 1 |
2 other studies available for pilocarpine and Arteriosclerosis, Coronary
Article | Year |
---|---|
Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Age Factors; Aged; Alzheimer Disease; Carbon | 2018 |
Coronary vasodilation impairment in pilocarpine model of epilepsy.
Topics: Animals; Coronary Artery Disease; Disease Models, Animal; Epilepsy; Male; Muscarinic Agonists; Piloc | 2019 |